PIN4 A BUDGET IMPACTO ANALYSIS OF TENOFOVIR ALAFENAMIDE/EMTRICITABINE (DESCOVY®) FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN PATIENTS AGED 12 YEARS AND OLDER, IN MEXICO
Abstract
Authors
P. Vera-Rendón M. Leal-González J.Á. Paladio Hernández L.T. Barrera-Balderas E.A. Devars-Cleren B.A. Godina-Ortiz